Liabooks Home|PRISM News
PRISM

#generative biology

Total 1 articles

The $1.3B Signal: Chai Discovery Isn't Just Another Biotech Unicorn, It's a Bet on Re-platforming Pharma
TechEN
The $1.3B Signal: Chai Discovery Isn't Just Another Biotech Unicorn, It's a Bet on Re-platforming Pharma

Chai Discovery's $1.3B valuation isn't just funding; it's a bet on 'Generative Biology.' Our analysis explores the impact on pharma R&D and investors.